CALIXAR team will be present at the online BIO International Convention, from June 10 to 11 and 14 to 18, 2021 to discuss about commercial and scientific opportunities linked to our activities.
CALIXAR is a biotech company specialized in the identification and isolation of functional membrane therapeutic targets and antigens (GPCRs, Ion channels, Transporters, …). The company is currently investing in the extension of its pipeline of highly druggable membrane protein targets and native antigens. Within the next few years, CALIXAR will be able to offer to Pharma & Biotech companies native and functional therapeutic targets validated and in a ready-to-discovery format.
CALIXAR wants to become a leader in the early discovery segment of drug development based on complex therapeutic targets (membrane proteins), a market predicted to be worth € 70 bn by 2025.
About BIO International Convention Digital
BIO Digital 2021 will convene leaders from across the biotech ecosystem for a re-imagined virtual experience. The biggest news this year is the Innovation Stage for startups, on 10 and 11 June, featuring a marketplace, business pitches, the Academic Campus, the NIH Innovation Zone, and more. The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.
For more information and meet us: Bio International Convention Digital